Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00598351 : Natural History Study of Patients With Neurofibromatosis Type 2
PhaseN/A
AgesMin: 8 Years Max: 75 Years
Eligibility
- INCLUSION CRITERIA:

- All patients will have the clinical diagnosis of NF2 by established clinical criteria
or genetic testing.

- Males and females between the ages of 8 and 75.

- Capacity to undergo serial MRI scanning of the CNS.

EXCLUSION CRITERIA:

- Clinically unstable condition that precludes serial clinical and imaging evaluation
(i.e. Class 3 congestive heart failure, severe chronic renal insufficiency, severe
chronic obstructive pulmonary disease).

- Allergy or relative contraindications to MRI contrast agents.

- Contraindication to MRI scanning such as surgery that involves metal clips or wires,
which might be expected to cause tissue damage or produce image artifacts.

- Patients with severe chronic renal insufficiency (glomerular filtration rate less
than 30 mL/min/1.73 m2), hepatorenal syndrome or post-liver transplantation.

- Patients who are pregnant at time of intake visit.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00598351      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740